Dans la même rubrique
-
Partager cette page
Carine De Vriese
Department of Pharmacotherapy and Pharmaceutics (DPP)
Unit of Pharmacology, Pharmacotherapy and Pharmaceutical care
ContactRESEARCH ACTIVITIES
Her research interests are in the field of clinic pharmacy, particularly at the level of the first line of care with community pharmacists.
Her research consists of implementation studies of pharmaceutical care in pharmacies, drug consumption analyses and development of new services in community pharmacy.
Her main research interests are in the areas of drug related problem detection, medication adherence and chronic disease screening in community pharmacy. Another part of her research focused on the field of nutrition, in the regulation of food intake through the study of ghrelin.
Selected publications
Rondeaux S, Braeckman T, Beckwé M, Biset N, Maesschalck J, Duquet N, De Wulf I, Devroey D, De Vriese C.Int J Environ Res Public Health. 2022 Jul 17;19(14):8699. doi: 10.3390/ijerph19148699.PMID: 35886551
Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children.
Biset N, Kestens W, Detemmerman D, Lona M, Karakaya G, Ceuppens A, Pochet S, De Vriese C.Int J Environ Res Public Health. 2022 Jan 4;19(1):548. doi: 10.3390/ijerph19010548.PMID: 35010808
Koubaity M, Lechon AS, Amighi K, Van Nuffelen M, Moreau M, Meert AP, De Vriese C.Support Care Cancer. 2021 Jul;29(7):3911-3919. doi: 10.1007/s00520-020-05916-w. Epub 2021 Jan 3.PMID: 33389085
Koubaity M, Lelubre M, Sansterre G, Amighi K, De Vriese C.Int J Clin Pharm. 2019 Feb;41(1):244-250. doi: 10.1007/s11096-018-0773-y. Epub 2019 Jan 4.PMID: 30610541
Implementation study of an intermediate medication review in Belgian community pharmacies.
Lelubre M, Wuyts J, Maesschalck J, Duquet N, Foubert K, Hutsebaut C, Moullin J, De Wulf I, Boussery K, Foulon V, De Vriese C.Res Social Adm Pharm. 2019 Jun;15(6):710-723. doi: 10.1016/j.sapharm.2018.09.002. Epub 2018 Sep 12.PMID: 30241873
Lelubre M, Hamdani J, Senterre C, Amighi K, Peres M, Schneider MP, Bugnon O, De Vriese C.Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):668-673. doi: 10.1002/pds.4441. Epub 2018 May 3.PMID: 29726056
Biset N, Lelubre M, Senterre C, Amighi K, Bugnon O, Schneider MP, De Vriese C.Patient Prefer Adherence. 2018 Jan 19;12:153-161. doi: 10.2147/PPA.S149355. eCollection 2018.PMID: 29403267
Focus on the short- and long-term effects of ghrelin on energy homeostasis.
De Vriese C, Perret J, Delporte C.Nutrition. 2010 Jun;26(6):579-84. doi: 10.1016/j.nut.2009.09.013. Epub 2010 Jan 15.PMID: 20080032 Review.
Ghrelin: a new peptide regulating growth hormone release and food intake.
De Vriese C, Delporte C.Int J Biochem Cell Biol. 2008;40(8):1420-4. doi: 10.1016/j.biocel.2007.04.020. Epub 2007 May 3.PMID: 17544318 Review.
Influence of ghrelin on food intake and energy homeostasis.
De Vriese C, Delporte C.Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):615-9. doi: 10.1097/MCO.0b013e32829fb37c.PMID: 17693746 Review.
Ghrelin interacts with human plasma lipoproteins.
De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C.Endocrinology. 2007 May;148(5):2355-62. doi: 10.1210/en.2006-1281. Epub 2007 Feb 8.PMID: 17289852
Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites.
De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C.Endocrinology. 2004 Nov;145(11):4997-5005. doi: 10.1210/en.2004-0569. Epub 2004 Jul 15.PMID: 15256494Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects
Wauthoz, N., Rosiere, R., & Amighi, K. (2020). Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects. Expert opinion on drug delivery. doi:10.1080/17425247.2021.1829590
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of gliobmastoma multiforme via intranasal administration
Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2016). Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of gliobmastoma multiforme via intranasal administration. Journal of controlled release, 227, 71-81. doi:10.1016/j.jconrel.2016.02.032
Development of Controlled-Release Cisplatin Dry Powders for Inhalation against Lung Cancers
Levet, V., Rosiere, R., Merlos, R., Fusaro, L., Berger, G., Amighi, K., & Wauthoz, N. (2016). Development of Controlled-Release Cisplatin Dry Powders for Inhalation against Lung Cancers. International journal of pharmaceutics, 515(1-2), 209-220. doi:10.1016/j.ijpharm.2016.10.019
New Inhalation-Optimized Itraconazole Nanoparticle-Based Dry Powders for the Treatment of Invasive Pulmonary Aspergillosis
Duret, C., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2012). New Inhalation-Optimized Itraconazole Nanoparticle-Based Dry Powders for the Treatment of Invasive Pulmonary Aspergillosis. International journal of nanomedicine, 7, 5475-5489. doi:10.2147/IJN.S34091
Lactose characteristics and the generation of the aerosol
Pilcer, G., Wauthoz, N., & Amighi, K. (2012). Lactose characteristics and the generation of the aerosol. Advanced drug delivery reviews, 64(3), doi:10.1016/j.addr.2011.05.003, 233-256.
Formulation strategy and use of excipients in pulmonary drug delivery.
Pilcer, G., & Amighi, K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. International journal of pharmaceutics, 392(1-2), 1-19. doi:10.1016/j.ijpharm.2010.03.017
Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients
Pilcer, G., Goole, J., Van Gansbeke, B., Blocklet, D., Knoop, C., Vanderbist, F., & Amighi, K. (2008). Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients. European journal of pharmaceutics and biopharmaceutics, 68(2), 413-421. doi:10.1016/j.ejpb.2007.05.005
Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation
Sebti, T., & Amighi, K. (2006). Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. European journal of pharmaceutics and biopharmaceutics, 63(1), 51-58. doi:10.1016/j.ejpb.2005.11.003
Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine
Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005). Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. International journal of pharmaceutics, 299(1-2), 167-177. doi:10.1016/j.ijpharm.2005.05.014
Surfactant induced drug delivery based on the use of thermosensitive polymers
Eeckman, F., Moës, A., & Amighi, K. (2003). Surfactant induced drug delivery based on the use of thermosensitive polymers. Journal of controlled release, 88(1), 105-116. doi:10.1016/S0168-3659(02)00457-1
Career
- 2020 - President of the National Council of the Order of Pharmacists
- 2019- Head of the unit of Pharmacology, Pharmacotherapy and Pharmaceutical care
- 2009- : Professor at the Faculty of Pharmacy, ULB
- 2007-2009 : Principal Scientist - Renal department of Baxter Research and Development Europe
- 2006-2007 : Assistant in the Department of Instrumental Analytical Chemistry and Bioelectrochemistry, Institute of Pharmacy, ULB.
- 2001-2006 : PhD in Pharmaceutical Sciences, Institute of Pharmacy, ULB. Title : « Study of the expression, production and degradation of ghrelin »
- 2001-2005 : FRIA Doctoral researcher in the Laboratory of Biological Chemistry and Nutrition, Faculty of Medicine, ULB
- 2001-2002 : Diplôme d’études approfondies interfacultaire en Sciences de la Santé : spécialisation Sciences Pharmaceutiques, Institute of Pharmacy, ULB
- 1996-2001 : Pharmacist with « la plus grande distinction », Institute of Pharmacy, ULB